These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
506 related articles for article (PubMed ID: 28956167)
1. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population. Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167 [TBL] [Abstract][Full Text] [Related]
2. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis]. Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960 [TBL] [Abstract][Full Text] [Related]
3. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity. Malla N; Kaul P; Sehgal R; Gupta I Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110 [TBL] [Abstract][Full Text] [Related]
4. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of Conventional Methods with Molecular Methods in the Diagnosis of Trichomonas vaginalis and Investigation of Metronidazole Resistance]. Özel Y; Çavuş İ; Usta A; Vardar Ünlü G; Özbilgin A; Ünlü M Mikrobiyol Bul; 2023 Oct; 57(4):625-638. PubMed ID: 37885390 [TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis. Müller M; Lossick JG; Gorrell TE Sex Transm Dis; 1988; 15(1):17-24. PubMed ID: 3258675 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of netropsin dihydrochloride against the viability, cytopathogenicity and hemolytic activity of Trichomonas vaginalis clinical isolates. Abou Gamra MM; Kamel HH; Ezz Eldin HM; Taha Zahran FM J Infect Chemother; 2019 Dec; 25(12):955-964. PubMed ID: 31189504 [TBL] [Abstract][Full Text] [Related]
8. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure. Bosserman EA; Helms DJ; Mosure DJ; Secor WE; Workowski KA Sex Transm Dis; 2011 Oct; 38(10):983-7. PubMed ID: 21934577 [TBL] [Abstract][Full Text] [Related]
9. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil. da Luz Becker D; dos Santos O; Frasson AP; de Vargas Rigo G; Macedo AJ; Tasca T Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and genetic diversity of Trichomonas vaginalis clinical isolates in a targeted population in Xinxiang City, Henan Province, China. Zhang Z; Kang L; Wang W; Zhao X; Li Y; Xie Q; Wang S; He T; Li H; Xiao T; Chen Y; Zuo S; Kong L; Li P; Li X Parasit Vectors; 2018 Mar; 11(1):124. PubMed ID: 29499747 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates. Abdel-Magied AA; Hammouda MM; Mosbah A; El-Henawy AA J Infect Chemother; 2017 Apr; 23(4):230-233. PubMed ID: 28131737 [TBL] [Abstract][Full Text] [Related]
13. Mycoplasma hominis infection of Trichomonas vaginalis is not associated with metronidazole-resistant trichomoniasis in clinical isolates from the United States. Butler SE; Augostini P; Secor WE Parasitol Res; 2010 Sep; 107(4):1023-7. PubMed ID: 20652315 [TBL] [Abstract][Full Text] [Related]
14. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro. Elwakil HS; Tawfik RA; Alam-Eldin YH; Nassar DA Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536 [TBL] [Abstract][Full Text] [Related]
15. Molecular typing of Trichomonas vaginalis isolates by actin gene sequence analysis and carriage of T. vaginalis viruses. Masha SC; Cools P; Crucitti T; Sanders EJ; Vaneechoutte M Parasit Vectors; 2017 Oct; 10(1):537. PubMed ID: 29084570 [TBL] [Abstract][Full Text] [Related]
16. Trichomonas vaginalis Virus Among Women With Trichomoniasis and Associations With Demographics, Clinical Outcomes, and Metronidazole Resistance. Graves KJ; Ghosh AP; Schmidt N; Augostini P; Secor WE; Schwebke JR; Martin DH; Kissinger PJ; Muzny CA Clin Infect Dis; 2019 Nov; 69(12):2170-2176. PubMed ID: 30768180 [TBL] [Abstract][Full Text] [Related]
17. Use of Trichomonas vaginalis clinical isolates to evaluate correlation of gene expression and metronidazole resistance. Mead JR; Fernadez M; Romagnoli PA; Secor WE J Parasitol; 2006 Feb; 92(1):196-9. PubMed ID: 16629339 [TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates. Snipes LJ; Gamard PM; Narcisi EM; Beard CB; Lehmann T; Secor WE J Clin Microbiol; 2000 Aug; 38(8):3004-9. PubMed ID: 10921968 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic options for the treatment of human trichomoniasis. Küng E; Fürnkranz U; Walochnik J Int J Antimicrob Agents; 2019 Feb; 53(2):116-127. PubMed ID: 30612993 [TBL] [Abstract][Full Text] [Related]
20. Lack of association between Mycoplasma hominis and Trichomonas vaginalis symbiosis in relation to metronidazole resistance. Mabaso N; Tinarwo P; Abbai N Parasitol Res; 2020 Dec; 119(12):4197-4204. PubMed ID: 33068149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]